ACLARUBICIN HYDROCHLORIDE
ACLARUBICIN HYDROCHLORIDE Basic information
- Product Name:
- ACLARUBICIN HYDROCHLORIDE
- Synonyms:
-
- aclacinomycinahydrochloride
- aclacinon
- n-2-yl)-alpha-l-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-l-lyxo-hexopyrano
- syl)oxy)-2,5,7-trihydroxy-,methylester,hydrochloride,(1r-(1-alpha,2-beta,4
- 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-alpha-l-lyxo-hexopyranosyl]-3-(dimethylamino)-alpha-l-lyxo
- ACLARUBICIN HYDROCHLORIDE
- 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, meth
- 1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, methyl ester, hydrochloride, [1R-(1α,2β,4β)]-
- CAS:
- 75443-99-1
- MF:
- C42H54ClNO15
- MW:
- 848.33
- EINECS:
- 278-209-3
- Product Categories:
-
- API
- Mol File:
- 75443-99-1.mol
ACLARUBICIN HYDROCHLORIDE Chemical Properties
- Melting point:
- 151-153℃
- Boiling point:
- 898℃
- Flash point:
- >110°(230°F)
- storage temp.
- 2-8°C
- solubility
- Soluble in DMSO or DMF at 25mg/ml
- form
- Solid
- color
- Light yellow to yellow
Safety Information
- Hazard Codes
- T
- Risk Statements
- 23/24/25
- Safety Statements
- 36/37/39-45
- RIDADR
- 3249
- RTECS
- QI9283500
- HazardClass
- 6.1(a)
- PackingGroup
- II
ACLARUBICIN HYDROCHLORIDE Usage And Synthesis
Definition
ChEBI: Aclarubicin hydrochloride is an anthracycline.
Biological Activity
Aclacinomycin A hydrochloride (Aclarubicin hydrochloride) is a fluorescent molecule and the first non-peptidic inhibitor discovered to have discrete specificity for the CTRL (chymotrypsin-like) activity of the 20S proteasome. It is also a dual inhibitor of topoisomerase I and II (topoisomerase I and II). It is an effective anthracycline chemotherapeutic agent for blood cancer and solid tumor related research.
in vitro
Aclacinomycin A could efficiently enter living cells and emit fluorescence in situ . Aclacinomycin A (10 μM for 15 min) is sufficient for clear detection of fluorescence in most of the cultured cells. Aclacinomycin A treatment (10 μM Acla for 15 min) results in approximately 20% dead (or nearly dead) cells.
Aclacinomycin A (Aclarubicin) effectively induces incorporation of exon 7 into SMN2 transcripts from the endogenous gene in type I SMA fibroblasts as well as into transcripts from a SMN2 minigene in the motor neuron cell line NSC34 .
in vivo
Aclarubicin hydrochloride(Aclacinomycin A) is very well absorbed in mice, rats, and dogs after its oral administration. The oral LD 50 (76.5 mg/kg) is about twice the iv LD 50 (35.6 mg/kg) in mice [4 .
Aclacinomycin A ( 0.75-6 mg/kg, ip daily) dose-dependently exhibits tumor growth in mice-based Leukemia P-388 model [4 .
Animal Model: | DBA/2, CDF 1 ( BALB/c×DBA/2) mice with Leukemia P-388 [4 . | tr>
Dosage: | 0.75 mg/kg, 1.5 mg/kg, 3 mg/kg, 6 mg/kg. | td>
Administration: | Intraperit oneal administration daily for 10 days starting 3 hr after transplantation. |
Result: | Inhibited tumor growth. |
target
20S proteasome.
Topoisomerase I and II.
ACLARUBICIN HYDROCHLORIDESupplier
- Tel
- 0086-21-67651709
- cfx759@hotmail.com
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
- Tel
- 15911056312
- liming@bio-fount.com
- Tel
- +86-0576-88813233 +86-13396860566
- sales@pharm-intermediates.com
- Tel
- Info@alfa-chemistry.com
ACLARUBICIN HYDROCHLORIDE(75443-99-1)Related Product Information
- ACLARUBICIN HYDROCHLORIDE
- 3-Methylphenylacetic acid
- 1,8-Dihydroxyanthraquinone
- (S)-(+)-Ketoprofen
- Methyl 2,2-dimethylphenylacetate
- 1,2,3,4-Tetrahydro-1-naphthoic acid
- 2-HYDROXY-5-METHYLBENZOPHENONE
- (S)-(+)-1,2,3,4-Tetrahydro-1-naphthol
- Methyl salicylate
- 3-BENZOYLPHENYLACETIC ACID
- 2-Amylanthraquinone
- 3-METHOXYETHOXYPROPYLAMINE
- Aclarubicin
- 5-(4-METHYLPHENYL)VALERIC ACID
- (2RS)-2-(4-ETHYLPHENYL)PROPANOIC ACID
- 2H-PYRAN-3(4H)-ONE, DIHYDRO-
- L-DaunosamineHCl
- 2-(2,5-DIMETHYLPHENYL)ACETALDEHYDE